Oppenheimer Asset Management Inc. lessened its stake in shares of TKO Group Holdings, Inc. (NYSE:TKO – Free Report) by 12.4% ...

Oppenheimer Asset Management Inc. lessened its position in Invesco S&P 500 High Beta ETF (NYSEARCA:SPHB – Free Report) by ...

Oppenheimer Holdings' profit margin is lacking behind key peers, particularly Morgan Stanley, who is also a key competitor.

Fintel reports that on March 5, 2025, Oppenheimer initiated coverage of Abeona Therapeutics (NasdaqCM:ABEO) with a Outperform ...

This is the story of Robert Oppenheimer, father of the atomic bomb. A brilliant man marred by pain and suffering. As tragic as some parts are, his life can teach us some valuable lessons.

If you missed Oppenheimer in IMAX you can get another chance to see it this weekend with a one-week USA and Canada rerelease ...

Christopher Nolan's Oppenheimer returned to theaters and is set to overtake Zack Snyder's Batman v. Superman as it climbs toward $1 billion.

Shogun star Cosmo Jarvis has joined the cast of Christopher Nolan's The Odyssey - and I don't think the cast list is ever ...

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) today and set a price target of ...

David Krumholtz unfortunately developed a rare and extremely dangerous disease, and he feels the need to publicly alert ...

Tactile Systems Technology, Inc. ("Tactile Medical”; the "Company”) (Nasdaq: TCMD), a medical technology company providing ...

Oppenheimer analyst Jay Olson lowered the firm’s price target on Denali Therapeutics (DNLI) to $42 from $50 and keeps an Outperform rating on the shares following quarterly results and after hosting ...